CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • How to Help CRI Raise Money for Crucial Cancer Immunotherapy Research This Giving Tuesday 

    “GivingTuesday is an opportunity for people around the world to use their individual power of generosity to…
    November 8, 2023| CRI Staff
  • CRI Hosts 2023 Annual Awards Dinner, Bestows Coley and Alt Awards on Immunotherapy Giants 

    NEW YORK — On November 6, 2023, the Cancer Research Institute (CRI) hosted its 2023 Annual Awards…
    November 7, 2023| CRI Staff
  • CRI Provides Latest Overview of the Field of PDx Trials 

    PD1 and PDL1 inhibitors, collectively referred to as PDx, have revolutionized cancer treatment since the approval of…
    November 3, 2023| CRI Staff
  • New Horizons Opened by Research and Generous Support

    A Conversation with Esther M Baird – Passionate Supporter of CRI Research Programs Why is funding scientists…
    October 27, 2023| CRI Staff
  • Dr. Jill O’Donnell-Tormey on the State of Cancer Immunotherapy and the Contributions CRI Continues to Make to the Field 

    iFrame is not supported! Recently, the Cancer Research Institute’s (CRI) CEO and Director of Scientific Affairs Jill…
    September 12, 2023| CRI Staff
  • Join #TeamCRI and Plan Your Own Tailgate for a Purpose

    The Cancer Research Institute (CRI) now has a new way to create a world immune to cancer,…
    August 30, 2023| CRI Staff
  • CRI’s Dr. Jill O’Donnell-Tormey Explains Five Things You Need to Know About Cancer Vaccines

    Vaccines had been effective at preventing viral and bacterial-borne viruses for two hundred years before the first…
    August 28, 2023| CRI Staff
  • A CRI Board Member’s Father was Diagnosed with Cancer – He Quickly Raised Over $150,000 for Research 

    It started with an idea. Yacov Arnopolin wanted to raise money for a cause that was close…
    August 21, 2023| CRI Staff
  • Dr. Jill O’Donnell-Tormey Discusses the Latest Developments in Immunological Technologies 

    CRI’s CEO and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey, recently spoke with ecancer about recent developments…
    August 16, 2023| CRI Staff

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2026, Cancer Research Institute

Trigger Donate Modal